Purification and characterization of recombinant sTRAIL expressed in Escherichia coli

Acta Biochimica et Biophysica Sinica

Volumn 36, Issue 2, 2004, Pages 118-122

  Xia, Xiao Xia ^a   Shen, Ya Ling ^a   Wei, Dong Zhi ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Characterization; Immobilized metal affinity chromatography; Inclusion bodies; Refolding; sTRAIL

Indexed keywords

RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AFFINITY CHROMATOGRAPHY; ARTICLE; BETA SHEET; CELL INCLUSION; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; DILUTION; ELECTROPHORESIS; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PANCREAS TUMOR; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

ESCHERICHIA COLI;

EID: 16544370373     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: 10.1093/abbs/36.2.118     Document Type: Article

References (24)

1. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995, 3(6): 673-682
2. Pitti RM, Marster SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem, 1996, 271(22): 12687-12690
3. Wang LH, Jiao BH. TRAIL: A new member of tumor necrosis factor superfamily. Prog Biochem Biophys, 1998, 25(5): 392-395
4. Walczak H, Miller RE, Ariall K, Gliniak B, Griffith TS, Kubin M, Chin W et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med, 1999, 5(2): 157-163
5. Cha SS, Kim MS, Choi YH, Sung BJ, Shin NK, Shin HC, Sung YC et al. 2.8 Å resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity, 1999, 11(2): 253-261
6. Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, Kelley RF, Ashkenazi A et al. Triggering cell death: The crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell, 1999, 4(4): 563-571
7. Wang LH, Zhu YP, Lou YH, Zhou JS, Peng YZ, Qiu Y, Jiao BH. High density cultivation for preparation of recombinant soluble human TRAIL. Acad J Sec Mil Med Univ, 2002, 23(2): 132-135
8. Wang XJ, Wu SL, Wei XC, Lin XL. The cloning, expression and refolding of TNF-related apoptosis inducing ligand. Journal of Beijing Medical University, 2000, 32(5): 387-390
9. Datar RV, Carrwright T, Rosen CG. Process economics of animal-cell and bacterial fermentations: A case study analysis of tissue plasminogen activator. Biotechnology (N Y), 1993, 11(3): 349-357
10. Marston FA, Lowe PA, Doel MT, Schoemaker JM, White S, Angal S. Purification of calf prochymosin (prorennin) synthesized in Escherichia coli. Biotechnology (N Y), 1984, 2(9): 800-804
11. Winkler ME, Blaber M, Bennett GL, Holmes W, Vehar GA. Purification and characterization of recombinant urokinase from Escherichia coli. Biotechnology (N Y), 1985, 3(11): 990-1000
12. Amons R, Schrier PI. Removal of sodium dodecyl sulfate from proteins and peptides by gel filtration. Anal Biochem, 1981, 116(2): 439-443
13. Vicik S, de Bernardez Clark E. An engineering approach to achieving high-protein refolding yields. ACS Symp Ser, 1991, 470: 180-196
14. Sinha NK, Light A. Refolding of reduced, denatured trypsinogen and trypsin immobilized on agarose beads. J Biol Chem, 1975, 250(22): 8624-8629
15. Hagen AJ, Hatton TA, Wang DIC. Protein refolding in reversed micelles. Biotechnol Bioeng, 1990, 35(10): 955-965
16. Schmidt M, Babu KR, Khanna N, Marten S, Rinas U. Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli. J Biotechnol, 1999, 68(1): 71-83
17. Wang LH, Feng Y, Zhu YP, Lou YH, Peng Y, Jiao BH. Expression of recombinant human TNF-related apoptosis-inducing ligand in Pichiapastoris. J Cell Mol Immunol, 2000, 16(5): 420-424
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of the protein-dye binding. Anal Biochem, 1976, 72: 248-254
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227: 680-685
20. Thatcher DR. Recovery of therapeutic proteins from inclusion bodies: Problems and process strategies. Biochem Soc Trans, 1990, 18(2): 234-235
21. Eck MJ, Sprang SR. The structure of tumor necrosis factor-α at 2.6 Å resolution. Implications for receptor binding. J Biol Chem, 1989, 264(29): 17595-17605
22. Eck MJ, Ultsch M, Rinderknecht E, de Vos AM, Sprang SR. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9 Å resolution. J Biol Chem, 1992, 267(4): 2119-2122
23. Hymowitz SG, O'Connel MP, Ultsch MH, Hurst A, Totpal K, Ashkenazi A, de Vos AM et al. A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry, 2000, 39(4): 633-640
24. Nam GH, Choi KY. Association of human tumor necrosis factor-related apoptosis inducing ligand with membrane upon acidification. Eur J Biochem, 2002, 269(21): 5280-5287